Your position:  Homepage

content

The Drug Information Portal of the Bund (Federal Government) and the Laender (States)

The portal PharmNet.Bund provides information of the competent authorities about drugs.

Attention please

The Drug Information System (AMIS) has been used for many years. Due to technical progress and insufficient assurance of functionality for the future, AMIS will be replaced by the successor database AmAnDa.

This process has been prepared intensively and is very complex. It is planned to complete the replacement in the near future, but the availability of sub-functions may be limited beyond the transitional period.

During the transitional phase, the previous AMIS database and thus also the public part of the AMIS database will be frozen to the status of March 19, 2020.

For Public Access

The information system contains administrative data concerning the authorisation of drugs as well as Summary of Product Characteristics (SPCs) and Patient Information Leaflets (PILs). Furthermore you can find information about:

  • Drug Information System
  • Pharmaceutical Brokers and Wholesaler
  • Clinical Trials

For Companies

Pharmaceutical companies and wholesaler are able to record their data and submit it online to the federal authorities. This includes:

  • Variation Submisson and Approval Exempt
  • Batch Releases
  • Results of Clinical Trials
  • Veterinary Sales

For National Authorities

National authorities are able to research and record national data online. These applications are restricted to staff members of the federal authorities and are only available in German.

Please note:

Use of the PharmNet name is made possible through the friendly approval of Cerner Deutschland GmbH that - as a provider for healthcare information technology solutions - offers software solutions for pharmaceutical management in hospital pharmacies under this trademark. DIMDI and Cerner Deutschland GmbH are not involved in a business relationship.

PharmNet.Bund.de is a cooperative project of the German regulatory authorities – Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)), the Paul-Ehrlich-Institut (PEI) and the Federal Office of Consumer Protection and Food Safety (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL)) – together with the Robert Koch Institute (RKI) and the German Institute of Medical Documentation and Information (Deutsches Institut für Medizinische Dokumentation und Information (DIMDI)). The project will be implemented in close cooperation with the competent authorities of the Laender coordinated by the Central Authority of the Laender for Health Protection with regard to Medicinal Products and Medical Devices (Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten (ZLG)).

Last modified: 3/23/20

Your position:  Homepage

This website uses session cookies to ensure login to closed areas. In order to optimize the website, we use the analysis tool Matomo. Our Matomo installation works without tracking cookies. You will find more detailed information and the possibilities to object to the use of Matomo in our data privacy declaration.